Neomenthol is a mint-family monoterpene alcohol and a stereoisomer of menthol that appears as a minor but recurrent constituent in peppermint-type oils. The live evidence base is still limited compared with menthol itself: identity data are clear, sensory-receptor work now shows that neomenthol stereochemistry changes TRPM8-channel interactions, and an older human trial found that D-neomenthol did not reproduce menthol's nasal-airflow sensation despite a similar smell. A newer open-access cancer-model paper exists, but it is preclinical and should not be translated into medical claims.
Chemical identity and composition
PubChem resolves neomenthol to C10H20O and shows several stereochemical records under the broader menthol scaffold, while NIST indexes CAS 491-01-0 as a specific cyclohexanol stereoisomer entry. The archive's mint-oil records place neomenthol as a secondary mint alcohol rather than a dominant cooling constituent like menthol.
Aroma and practical use
- Use the recorded minty, cooling, peppermint-like, herbal, herbaceous descriptors to explore a blend's scent character; perceived strength also depends on the other ingredients.
- Review the flagged use concerns across every contributing oil and the selected dilution.
- Read the route, preparation and experimental context before using a study finding to choose an oil.
Reported benefits and effects
Findings retain their study context. An animal or laboratory result describes that experiment.
A randomized human study in 40 subjects found that inhaled D-neomenthol did not enhance the sensation of nasal airflow, whereas L-menthol did.
This is one of the few direct human datasets for neomenthol and is useful precisely because it argues against casually borrowing menthol's hallmark sensory claim.
Apply this finding only to the studied preparation, participants, route and outcome. It does not establish the same result for a custom oil blend.
A 2022 full-text TRPM8 study reported that (+)-neomenthol and related menthol stereoisomers activate TRPM8 through similar overall mechanisms but with different ligand-residue interactions.
This supports a receptor-level explanation for why menthol isomers can smell similar while differing in cooling perception.
This experimental finding does not establish benefit, dose or safety in people using this blend.
A 2021 open-access study reported that neomenthol inhibited A431 epidermoid carcinoma cell proliferation, arrested cells in G2/M phase, inhibited hyaluronidase, affected tubulin polymerization, and reduced EAC tumor formation in mice.
The paper is mechanistically detailed but remains far outside a wellness-aroma evidence tier and should be presented only as exploratory pharmacology.
This experimental finding does not establish benefit, dose or safety in people using this blend.
A classic rabbit metabolism paper described biological reduction of l-menthone to d-neomenthol and subsequent glucuronic-acid conjugation behavior.
This older paper is still useful for basic metabolism context linking neomenthol to mint ketone reduction pathways.
This experimental finding does not establish benefit, dose or safety in people using this blend.
Use concerns and concentration limits
Sensitization concernFlagged
Flagged in the constituent reference; assess the source, route and finished-product concentration.
Phototoxicity concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Oxidation concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Penetration enhancementNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
A recorded constituent reference, not a recommended oil dilution. Product category, source applicability and all contributing oils must be checked before use.
unverified reference · No source provenance attachedNo constituent-specific public dermal maximum or similarly clear modern fragrance-use restriction for isolated neomenthol was verified in this pass.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
The most directly relevant human evidence reviewed here is sensory and negative-for-airflow rather than therapeutic, so archive copy should not substitute menthol claims onto neomenthol.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
The available benefit-facing literature is preclinical and disease-model oriented, not evidence for general inhalation or topical wellness use.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
Constituents it may interact with
No constituent-pair interaction is recorded for this identity. The report does not assume either amplification or incompatibility.
How the effects were investigated
TRPM8 interaction varies with menthol stereochemistry
A 2022 TRPM8 paper comparing menthol stereoisomers reported that (+)-neomenthol engages the menthol receptor through a related but not identical binding configuration, supporting stereochemistry-sensitive cooling-channel pharmacology.
This experimental finding does not establish benefit, dose or safety in people using this blend.
lack of menthol-like nasal airflow effect in humans
The randomized 1988 human study indicates that D-neomenthol does not reproduce L-menthol's airflow-sensation effect, implying that odor similarity alone does not predict the same sensory-nerve action.
Apply this finding only to the studied preparation, participants, route and outcome. It does not establish the same result for a custom oil blend.
tubulin polymerization and hyaluronidase inhibition in cancer models
The 2021 open-access neomenthol paper proposed growth-delay effects in A431 and mouse EAC models through tubulin and hyaluronidase-linked pathways, but this remains disease-model pharmacology rather than aroma-use evidence.
This experimental finding does not establish benefit, dose or safety in people using this blend.
What this report cannot establish
- A reported constituent percentage does not establish an effective human therapeutic dose or the amount absorbed into the body.
- The presence of a constituent does not guarantee a clinical benefit, rash treatment or sleep improvement from a custom blend.
- An unflagged concern or missing use limit does not establish safety for ingestion, inhalation, skin exposure or a particular person.
- A candidate constituent interaction does not establish that two oils amplify one another at the selected proportions.
- Constituent descriptors alone do not establish a precise top, heart or base lifetime in a finished blend.
Known data gaps (5)
- Direct constituent-level human research on isolated neomenthol is sparse and largely limited to sensory work rather than efficacy trials.
- No clearly readable public sensitization dataset or constituent-specific leave-on dermal limit was verified for isolated neomenthol in this pass.
- Much of the newer neomenthol literature is pharmacology-oriented and may not translate to aroma-use contexts.
- The numeric dermal reference lacks source provenance; a verified flag alone is insufficient.
- Some findings do not record an explicit exposure route; consult the linked study before applying them to a use.